Please login to the form below

Not currently logged in
Email:
Password:

Rosetta merges with Razorfish Healthware to launch new agency

Merger will create Razorfish Health
Razorfish logo

Publicis Healthcare Communications Group (PHCG) has revealed that part of Rosetta's healthcare business is to merge into Razorfish Healthware to create Razorfish Health.

The engagement, creative and media segment of Rosetta's healthcare business will merge in the US with PHCG's existing agency, Razorfish Healthware.

Nick Colucci, CEO of PHCG, commented: “As health and wellness clients grapple with the accelerating transformation of healthcare in a digital world, the new Razorfish Health is ideally positioned to bring its combined expertise in engagement, innovation and technology to deliver better health outcomes for our clients.”

Rosetta's healthcare business, in regards to commerce, enterprise technology platforms and growth strategy consulting will remain at Rosetta under its East Region.
Shannon Hartley, previous leader of Rosetta's Healthcare Industry Group, will take the role of managing director of Razorfish Health, taking over US operations.

The new agency will report to PHCG president Janet Winkler, who additionally oversees North American operations of Saatchi & Saatchi Wellness, in-sync Customer Insights, Discovery USA, Maxcess and Verilogue.

Article by
Kirstie Pickering

25th February 2015

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics